RESUMO
BACKGROUND: The inflammation in the lungs and other vital organs in COVID-19 are characterized by the presence of neutrophils and high concentration of neutrophil extracellular traps (NETs), which also seems to mediate host tissue damage. However, it is not known whether NETs could have virucidal activity against SARS-CoV-2. METHODS: We investigated whether NETs could prevent SARS-CoV-2 replication in neutrophils and epithelial cells, and what the consequence of NETs degradation in K18-humanized ACE2 transgenic mice infected with SARS-CoV-2. RESULTS: Here, by immunofluorescence microscopy we observed that viral particles co-localize with NETs in neutrophils isolated from COVID-19 patients or from healthy individuals and infected in vitro. The inhibition of NETs production increased virus replication in neutrophils. In parallel, we observed that NETs inhibited virus abilities to infect and replicate in epithelial cells after 24â h of infection. Degradation of NETs with DNase I prevented their virucidal effect in vitro. Using K18-humanized ACE2 transgenic mice we observed a higher viral load in animals treated with DNase I. On the other hand, the virucidal effect of NETs was not dependent on neutrophil elastase or myeloperoxidase activity. CONCLUSION: Our results provide evidence of the role of NETosis as a mechanism of SARS-CoV-2 viral capture and inhibition.
RESUMO
BACKGROUND: Previous data have reported that the growth of established tumors may be facilitated by postsepsis disorder through changes in the microenvironment and immune dysfunction. However, the influence of postsepsis disorder in initial carcinogenesis remains elusive. METHODS: In the present work, the effect of postsepsis on inflammation-induced early carcinogenesis was evaluated in an experimental model of colitis-associated colorectal cancer (CAC). We also analyzed the frequency and role of intestinal T regulatory cells (Treg) in CAC carcinogenesis. RESULTS: The colitis grade and the tumor development rate were evaluated postmortem or in vivo through serial colonoscopies. Sepsis-surviving mice (SSM) presented with a lower colonic DNA damage, polyp incidence, reduced tumor load, and milder colitis than their sham-operated counterparts. Ablating Treg led to restoration of the ability to develop colitis and tumor polyps in the SSM, in a similar fashion to that in the sham-operated mice. On the other hand, the growth of subcutaneously inoculated MC38luc colorectal cancer cells or previously established chemical CAC tumors was increased in SSM. CONCLUSION: Our results provide evidence that postsepsis disorder has a dual effect in cancer development, inhibiting inflammation-induced early carcinogenesis in a Treg-dependent manner, while increasing the growth of previously established tumors.
Assuntos
Colite/complicações , Neoplasias do Colo/patologia , Modelos Animais de Doenças , Inflamação/complicações , Sepse/complicações , Linfócitos T Reguladores/imunologia , Microambiente Tumoral/imunologia , Animais , Colite/imunologia , Colite/patologia , Neoplasias do Colo/etiologia , Citocinas/metabolismo , Feminino , Inflamação/patologia , Camundongos , Camundongos Endogâmicos C57BL , Sepse/imunologia , Sepse/patologia , Transdução de SinaisRESUMO
Ifosfamide (IFO) is an antineoplastic drug that is commonly used to treat gynecological and breast cancers. Hemorrhagic cystitis (HC) is a common side effect associated with IFO injection, which courses with neutrophil accumulation and affects 6-50% of patients depending on dose intensity. Here, we investigated the role of neutrophils in this inflammatory process. Female Swiss mice (nâ¯=â¯8/group) were injected with saline, IFO (400â¯mg/kg, i.p.), fucoidan (a P- and L-selectins inhibitor, 100â¯mg/kg, i.v.) or IFOâ¯+â¯fucoidan (1-100â¯mg/kg) alone or combined with mesna (80â¯mg/kg i.p.). Another group of mice received anti-Ly6G antibody (500⯵g/mouse, once daily for 2â¯days) for neutrophil depletion before IFO injection. In another experimental setting, animals received granulocyte colony-stimulating factor (G-CSF, 400⯵g/kg), IFO (200â¯mg/kg), G-CSF (25-400⯵g/kg, for 5â¯days)â¯+â¯IFO (200â¯mg/kg, i.p.) or fucoidanâ¯+â¯G-CSFâ¯+â¯IFO. Bladder injury was evaluated 12â¯h after IFO injection. IFO 400â¯mg/kg significantly increased visceral hyperalgesia, bladder edema, hemorrhage, vascular permeability, MPO, IL-1ß and IL-6 tissue levels, and COX-2 immunostaining and expression versus the saline group (Pâ¯<â¯0.05). Conversely, fucoidan (100â¯mg/kg) significantly attenuated these parameters compared to IFO-injected mice (Pâ¯<â¯0.05). Additionally, fucoidan potentiated mesna protective effect when compared with IFOâ¯+â¯mesna group (Pâ¯<â¯0.05). Accordingly, neutrophil depletion with anti-Ly6G reduced inflammatory parameters and bladder injury compared to IFO (Pâ¯<â¯0.05). In contrast, G-CSF enhanced IFO (200â¯mg/kg)-induced HC, which was significantly attenuated by treatment with fucoidan (Pâ¯<â¯0.05). Therefore, neutrophils contribute to the pathogenesis of HC.